Neurocrine Biosciences, Inc. (NBIX)

127.57 -1.06 (-0.82%) USD  |  NASDAQ  |  Feb 23, 11:00
More

Neurocrine Biosciences Non-Operating Interest Expense (Quarterly)

Non-Operating Interest Expense (Quarterly) Chart

View Non-Operating Interest Expense (Quarterly) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Operating Interest Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Operating Interest Expense (Quarterly) Range, Past 5 Years

View Non-Operating Interest Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Operating Interest Expense (Quarterly) Benchmarks

View Non-Operating Interest Expense (Quarterly) Benchmarks
Start Trial
Glaukos Corp. Upgrade
Edgewise Therapeutics, Inc. Upgrade
Nuvalent, Inc. Upgrade
Marker Therapeutics, Inc. Upgrade
CapsoVision, Inc. Upgrade